Vitiligo: a complex disease and a complex approach.
作者信息
Begum Rasheedunnisa, Marfatia Yogesh S, Laddha Naresh C, Dwivedi Mitesh, Mansuri Mohmmad Shoab, Singh Mala
机构信息
Department of Biochemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, India.
Department of Skin & V.D., Faculty of Medicine, The Maharaja Sayajirao University of Baroda, Vadodara, India.
出版信息
Mol Cytogenet. 2014 Jan 21;7(Suppl 1 Proceedings of the International Conference on Human):I57. doi: 10.1186/1755-8166-7-S1-I57. eCollection 2014.
Abstract
摘要
相似文献
1
Vitiligo: a complex disease and a complex approach.
Mol Cytogenet. 2014 Jan 21;7(Suppl 1 Proceedings of the International Conference on Human):I57. doi: 10.1186/1755-8166-7-S1-I57. eCollection 2014.
2
A Parametric Targetability Evaluation Approach for Vitiligo Proteome Extracted through Integration of Gene Ontologies and Protein Interaction Topologies.
IEEE/ACM Trans Comput Biol Bioinform. 2019 Nov-Dec;16(6):1830-1842. doi: 10.1109/TCBB.2018.2835459. Epub 2018 May 17.
3
VitiVar: A locus specific database of vitiligo associated genes and variations.
Gene. 2019;721S:100018. doi: 10.1016/j.gene.2019.100018. Epub 2019 May 11.
4
VitiVar: A locus specific database of vitiligo associated genes and variations.
Gene X. 2019 May 11;3:100018. doi: 10.1016/j.gene.2019.100018. eCollection 2019 Sep.
5
The Genetic Basis of Vitiligo.
J Invest Dermatol. 2021 Feb;141(2):265-273. doi: 10.1016/j.jid.2020.06.004. Epub 2020 Aug 8.
6
Immunological pathomechanisms in vitiligo.
Expert Rev Mol Med. 2001 Jul 23;3(20):1-22. doi: 10.1017/S1462399401003362.
7
Modern vitiligo genetics sheds new light on an ancient disease.
J Dermatol. 2013 May;40(5):310-8. doi: 10.1111/1346-8138.12147.
8
Impact of Ultraviolet Light on Vitiligo.
Adv Exp Med Biol. 2017;996:55-60. doi: 10.1007/978-3-319-56017-5_5.
9
Response of localized, resistant, tingling vitiligo to pregabalin: A case report.
Dermatol Ther. 2018 Nov;31(6):e12702. doi: 10.1111/dth.12702. Epub 2018 Nov 19.
10
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
J Invest Dermatol. 2001 Aug;117(2):326-32. doi: 10.1046/j.1523-1747.2001.01408.x.
引用本文的文献
1
Reliability, Validity and Feasibility of the Vitiligo Extent Score (VES) and Self-Assessment Vitiligo Extent Score (SA-VES) Among Vitiligo Patients: A Cross-Cultural Validation.
Clin Cosmet Investig Dermatol. 2021 Jul 28;14:949-957. doi: 10.2147/CCID.S324073. eCollection 2021.
2
Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.
An Bras Dermatol. 2016 Apr;91(2):187-95. doi: 10.1590/abd1806-4841.20164012.
3
Plasma Levels of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Sudanese Patients with Vitiligo: A Case-Control Study.
Indian J Dermatol. 2015 Nov-Dec;60(6):635. doi: 10.4103/0019-5154.169136.
4
Successful management of insulin allergy and autoimmune polyendocrine syndrome type 4 with desensitization therapy and glucocorticoid treatment: a case report and review of the literature.
Case Reports Immunol. 2014;2014:394754. doi: 10.1155/2014/394754. Epub 2014 Nov 19.
Zotero 插件